Analysts Set Elevance Health, Inc. (NYSE:ELV) Price Target at $601.64
Shares of Elevance Health, Inc. (NYSE:ELV – Get Free Report) have earned a consensus rating of “Buy” from the sixteen analysts that are covering the firm, MarketBeat Ratings reports. One research analyst has rated the stock with a hold recommendation, fourteen have assigned a buy recommendation and one has given a strong buy recommendation to […]
More Stories
Analyzing Mercury General (NYSE:MCY) & Deep Yellow (OTCMKTS:DYLLF)
Volatility & Risk Mercury General has a beta of 0.87, indicating that its stock price is 13% less volatile than...
Analyzing Mercury General (NYSE:MCY) & Deep Yellow (OTCMKTS:DYLLF)
Volatility & Risk Mercury General has a beta of 0.87, indicating that its stock price is 13% less volatile than...
Y-mAbs Therapeutics (NASDAQ:YMAB) Earns “Outperform” Rating from Wedbush
Y-mAbs Therapeutics (NASDAQ:YMAB – Get Free Report)‘s stock had its “outperform” rating reiterated by analysts at Wedbush in a research...
Y-mAbs Therapeutics (NASDAQ:YMAB) Earns “Outperform” Rating from Wedbush
Y-mAbs Therapeutics (NASDAQ:YMAB – Get Free Report)‘s stock had its “outperform” rating reiterated by analysts at Wedbush in a research...
VR Resources (CVE:VRR) Trading Down 16.7% – Here’s What Happened
VR Resources Ltd. (CVE:VRR – Get Free Report)’s share price traded down 16.7% during trading on Friday . The company...
VR Resources (CVE:VRR) Trading Down 16.7% – Here’s What Happened
VR Resources Ltd. (CVE:VRR – Get Free Report)’s share price traded down 16.7% during trading on Friday . The company...